Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sirolimus × Other solid neoplasm × Clear all

Phase

Phase 1 12 Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 39 Lymphoid 33 Sarcoma 21 Myeloid 20 Plasma cell 12 Gynecologic 9 Dermatologic 9 Gastrointestinal 8 CNS 8 Breast 6 Genitourinary 4 Classical hematology 4 Head & Neck 3 Thoracic 2 Other neoplasm 2 Tumor-Agnostic 1 Other solid neoplasm 1

Conditions

Interventions

Cisplatin 42 Pemetrexed 31 Carboplatin 28 Nivolumab 21 pembrolizumab 19 Gemcitabine 19 atezolizumab 13 Etoposide 13 Injections 12 Ipilimumab 11 Cyclophosphamide 11 Radiotherapy 10 Oxaliplatin 10 Filgrastim 10 Docetaxel 10 Bevacizumab 10 tislelizumab 9 Vincristine 9 Specimen Handling 9 durvalumab 8 Paclitaxel 8 Capecitabine 8 tremelimumab 7 toripalimab 7 lenvatinib 7 Everolimus 7 spartalizumab 6 olaparib 6 niraparib 6 Vinorelbine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡